eflornithine has been researched along with Adenoma, Prostatic in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harvengt, C | 1 |
| Dunzendorfer, U | 1 |
| Knöner, M | 1 |
2 other studies available for eflornithine and Adenoma, Prostatic
| Article | Year |
|---|---|
Drugs recently released in Belgium. Eflornithine--finasteride.
Topics: Eflornithine; Finasteride; Humans; Male; Prostatic Hyperplasia | 1994 |
[Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Topics: Adenocarcinoma; Adenosylmethionine Decarboxylase; Animals; Antineoplastic Agents; Carboxy-Lyases; Ca | 1985 |